Daniel Plano received his B.Sc. degree in Chemistry from the University of Navarra at Pamplona. He also received a European Ph.D. degree in Science (Chemistry), awarded with an Extraordinary Ph.D. issued in 2010 by the School of Science of the University of Navarra (Spain). In 2011, he received a postdoctoral fellowship from Navarra’s Government and joined the laboratory of A. K. Sharma, where he was mainly working on developing novel small drug-like molecules for cancer prevention and therapy. In 2014, he became an Assistant Professor in the Department of Pharmaceutical Technology and Chemistry at the University of Navarra. Currently, he is a Full Professor of Organic Chemistry at the same institution. In 2019, he was adjudged with a “JoséCastillejo” scholarship granted by the Spanish Government to join Dr.
Sharma’s lab for 3 months. He has published many articles, related to selenium derivatives with bioactivity against several illnesses including cancer, Alzheimer’s disease, and leishmaniasis.
Daniel Plano received his B.Sc. degree in Chemistry from the University of Navarra at Pamplona. He also received a European Ph.D. degree in Science (Chemistry), awarded with an Extraordinary Ph.D. issued in 2010 by the School of Science of the University of Navarra (Spain). In 2011, he received a postdoctoral fellowship from Navarra’s Government and joined the laboratory of A. K. Sharma, where he was mainly working on developing novel small drug-like molecules for cancer prevention and therapy. In 2014, he became an Assistant Professor in the Department of Pharmaceutical Technology and Chemistry at the University of Navarra. Currently, he is a Full Professor of Organic Chemistry at the same institution. In 2019, he was adjudged with a “JoséCastillejo” scholarship granted by the Spanish Government to join Dr.
Sharma’s lab for 3 months. He has published many articles, related to selenium derivatives with bioactivity against several illnesses including cancer, Alzheimer’s disease, and leishmaniasis.